MiMedx Group, Inc. (MDXG)
4.50
-0.01
(-0.22%)
USD |
NASDAQ |
Aug 28, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
MiMedx Group Cash and Short Term Investments (Quarterly) : 135.84M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 135.84M |
| March 31, 2026 | 159.77M |
| December 31, 2025 | 166.12M |
| September 30, 2025 | 142.08M |
| June 30, 2025 | 118.87M |
| March 31, 2025 | 106.43M |
| December 31, 2024 | 104.42M |
| September 30, 2024 | 88.80M |
| June 30, 2024 | 69.04M |
| March 31, 2024 | 48.49M |
| December 31, 2023 | 82.00M |
| September 30, 2023 | 81.16M |
| June 30, 2023 | 68.65M |
| March 31, 2023 | 61.22M |
| December 31, 2022 | 65.95M |
| September 30, 2022 | 73.22M |
| June 30, 2022 | 72.50M |
| March 31, 2022 | 75.68M |
| December 31, 2021 | 87.08M |
| September 30, 2021 | 90.61M |
| June 30, 2021 | 85.01M |
| March 31, 2021 | 84.75M |
| December 31, 2020 | 95.81M |
| September 30, 2020 | 109.60M |
| June 30, 2020 | 48.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 53.52M |
| December 31, 2019 | 69.07M |
| September 30, 2019 | 94.12M |
| June 30, 2019 | 96.93M |
| March 31, 2019 | 28.38M |
| December 31, 2018 | 45.12M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 27.48M |
| September 30, 2017 | 36.52M |
| June 30, 2017 | 47.53M |
| March 31, 2017 | 30.92M |
| December 31, 2016 | 34.39M |
| September 30, 2016 | 18.34M |
| June 30, 2016 | 23.80M |
| March 31, 2016 | 17.62M |
| December 31, 2015 | 31.49M |
| September 30, 2015 | 47.57M |
| June 30, 2015 | 45.85M |
| March 31, 2015 | 44.70M |
| December 31, 2014 | 52.33M |
| September 30, 2014 | 47.25M |
| June 30, 2014 | 39.25M |
| March 31, 2014 | 43.02M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 38.41M |
| Perspective Therapeutics, Inc. | 236.88M |
| ABVC BioPharma, Inc. | 0.0944M |
| Enovis Corp. | 12.56M |
| Edwards Lifesciences Corp. | 4.255B |